Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05832580 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum

Study acronym: TEMP-PREVENT
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this randomized clinical trial is to assess the effect of etidronate on ectopic calcification in relatively young patients with Pseudoxanthoma elasticum. The main question it aims to answer are: What is the difference in the arterial calcification scores in the legs and the carotid syphon measured on low-dose CT scan after 24 months of treatment compared to baseline between etidronate and placebo. Participants will be asked to do take etidronate or placebo for 24 months.
Trial Details
NCT Number NCT05832580
Lead Sponsor UMC Utrecht
Conditions
(from sponsor)		 Pseudoxanthoma Elasticum
Related terms Pseudoxanthoma Elasticum
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov